Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected Countries.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2017.23.2.247
Abstract: BACKGROUND Global pharmaceutical sales for anticancer drugs were $74.4 billion in 2014, ranking first for drugs by therapeutic class. Countries may differ substantially in the approval and coverage decisions for anticancer drugs. OBJECTIVE To compare… read more here.
Keywords: coverage decisions; drug indications; oncology; approval coverage ... See more keywords